Cara Therapeutics (CARA)
(Delayed Data from NSDQ)
$0.91 USD
+0.04 (4.72%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $0.89 -0.02 (-2.20%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.40 | 4.54% |
Earnings Summary
For their last quarter, Cara Therapeutics (CARA) reported earnings of -$0.59 per share, missing the Zacks Consensus Estimate of -$0.57 per share. This reflects a negative earnings surprise of 3.51%. Look out for CARA's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.40 per share, reflecting a year-over-year increase of 18.37%.
Earnings History
Price & Consensus
Zacks News for CARA
CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%
CARA: What are Zacks experts saying now?
Zacks Private Portfolio Services